QMT-20040-53694
4 vaccinations
7 coded responses
26 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 970 / OR
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 1 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-07
-
2021-02-08
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-10
Health check-in — day 7, dose 1Feeling: Fair · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-18
-
2021-02-21
Dose 2 — Pfizer-BioNTech
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Swollen lymphnode under armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Unevaluable event — Feeling: Fair · Fatigue or tiredness · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Lymphnode swellung size of a gulf ball in the armpit · Healthcare visit (other): Home health nurseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-26
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: Lymphnode swellung under armpit size of a gulf ball stillMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
- 2021-03-07
- 2021-03-14
-
2021-03-28
Survey response — day 35, dose 2MedDRA: Wheezing — Feeling: FairFree text: WheezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-23
- 2021-08-22
- 2021-09-07
-
2021-10-07
Dose 3 — Pfizer-BioNTech
-
2022-02-21
Survey response — 12 months, dose 2MedDRA: COVID-19, Dizziness, Loss of consciousness, Pneumothorax — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Has collapsed lung from covid a few weeks ago. Is now having black outs and dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-21
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-02-23
-
2022-04-07
Dose 4 — Pfizer-BioNTech
- 2022-04-19
- 2022-04-23
- 2022-04-28
- 2022-05-07
- 2022-05-12
- 2022-05-21
- 2022-07-08
-
2022-10-06
Survey response — 6 months, dose 4MedDRA: Cough, Dizziness, Wheezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cough, wheezing, dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2023-04-07
Survey response — 12 months, dose 4MedDRA: Cardiac failure, Pulmonary hypertension — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-07
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2023-04-12
- 2023-04-12
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-02-21 | Pfizer-BioNTech | |
| 3 | 2021-10-07 | Pfizer-BioNTech | No |
| 4 | 2022-04-07 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymphnode under armpit
Systemic reaction (other): Lymphnode swellung size of a gulf ball in the armpit
Healthcare visit (other): Home health nurse
Systemic reaction (other): Lymphnode swellung under armpit size of a gulf ball still
Release 6 — day 35, dose 2
Symptoms: Wheezing
Release 11 — 12 months, dose 2
Symptoms: Has collapsed lung from covid a few weeks ago. Is now having black outs and dizziness
Release 12 — 6 months, dose 4
Symptoms: Cough, wheezing, dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Cardiac failure | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Loss of consciousness | · | · | ✓ |
| SD | Pneumothorax | · | · | ✓ |
| SD | Pulmonary hypertension | · | · | ✓ |
| SD | Wheezing | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release